These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 14969852

  • 1. Inhibition of hepatitis C virus-transfected cholangiocarcinoma by antisense oligodeoxynucleotide in nude mice.
    Liu XF, Zhou XT, Zou SQ.
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):115-9. PubMed ID: 14969852
    [Abstract] [Full Text] [Related]

  • 2. [Inhibition of hepatitis C virus by antisense oligodeoxynucleotide in vitro].
    Liu Y, Chen Z, He N.
    Zhonghua Yi Xue Za Zhi; 1997 Aug; 77(8):567-70. PubMed ID: 9772458
    [Abstract] [Full Text] [Related]

  • 3. Expression of nuclear factor kappa B in hepatitis C virus core gene transfected cholangiocarcinoma cells.
    Liu X, Zou S, Qiu F.
    Chin Med J (Engl); 2002 Jul; 115(7):998-1001. PubMed ID: 12150729
    [Abstract] [Full Text] [Related]

  • 4. [NF-kappa B expression in cholangiocarcinoma transfected with hepatitis C virus core gene].
    Liu X, Zou S, Qiu F.
    Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):20-3. PubMed ID: 11977629
    [Abstract] [Full Text] [Related]

  • 5. Detection of hepatitis C virus RNA sequences in hepatic portal cholangiocarcinoma tissue by reverse transcription polymerase chain reaction.
    Yin F, Chen B.
    Chin Med J (Engl); 1998 Dec; 111(12):1068-70. PubMed ID: 11263365
    [Abstract] [Full Text] [Related]

  • 6. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
    Alt M, Renz R, Hofschneider PH, Paumgartner G, Caselmann WH.
    Hepatology; 1995 Sep; 22(3):707-17. PubMed ID: 7657273
    [Abstract] [Full Text] [Related]

  • 7. Malignant transformation of the cultured human normal biliary tract epithelial cells induced by hepatitis C virus core protein.
    Chen RF, Li ZH, Liu RY, Kong XH, Tang QB, Wang J.
    Oncol Rep; 2007 Jan; 17(1):105-10. PubMed ID: 17143485
    [Abstract] [Full Text] [Related]

  • 8. Effect of hepatitis C virus core protein on modulation of cellular proliferation and apoptosis in hilar cholangiocarcinoma.
    Chen RF, Li ZH, Zou SQ, Chen JS.
    Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):71-4. PubMed ID: 15730924
    [Abstract] [Full Text] [Related]

  • 9. Detection of hepatitis C virus RNA sequences in cholangiocarcinomas in Chinese and American patients.
    Lu H, Ye MQ, Thung SN, Dash S, Gerber MA.
    Chin Med J (Engl); 2000 Dec; 113(12):1138-41. PubMed ID: 11776153
    [Abstract] [Full Text] [Related]

  • 10. [Effect of Bcl-2 antisense phosphorothioate oligodeoxynucleotides on bile duct carcinoma cell line QBC939].
    Peng C, Tang HH, Huang P, Chen MX.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):536-9. PubMed ID: 16320583
    [Abstract] [Full Text] [Related]

  • 11. [Human normal biliary epithelial cells transformation and tumor development induced by hepatitis C virus core protein].
    Chen RF, Li ZH, Chen JS, Kong XH, Zou SQ.
    Zhonghua Wai Ke Za Zhi; 2005 Feb 01; 43(3):153-6. PubMed ID: 15842891
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of hepatitis C virus replication by antisense oligonucleotide in culture cells.
    Mizutani T, Kato N, Hirota M, Sugiyama K, Murakami A, Shimotohno K.
    Biochem Biophys Res Commun; 1995 Jul 26; 212(3):906-11. PubMed ID: 7626129
    [Abstract] [Full Text] [Related]

  • 13. [Effect of vascular endothelial growth factor antisense oligodeoxynucleotides on angiogenesis in lymphoma of nude mice].
    Tong YJ, Zhang M, Zou P, Guo R, Yuan YH.
    Ai Zheng; 2005 Jan 26; 24(1):62-6. PubMed ID: 15642202
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States.
    Perumal V, Wang J, Thuluvath P, Choti M, Torbenson M.
    Hum Pathol; 2006 Sep 26; 37(9):1211-6. PubMed ID: 16938527
    [Abstract] [Full Text] [Related]

  • 15. Conjugation of an antisense oligodeoxynucleotide to ribonuclease h results in sequence-specific cleavage and intracellular inhibition of HCV gene expression.
    Fukuma T, Walton CM, Wu CH, Wu GY.
    Bioconjug Chem; 2003 Sep 26; 14(2):295-301. PubMed ID: 12643739
    [Abstract] [Full Text] [Related]

  • 16. Construction of HCV-core gene vector and its expression in cholangiocarcinoma.
    Liu XF, Zou SQ, Qiu FZ.
    World J Gastroenterol; 2002 Feb 26; 8(1):135-8. PubMed ID: 11833089
    [Abstract] [Full Text] [Related]

  • 17. Epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma.
    Li T, Li D, Cheng L, Wu H, Gao Z, Liu Z, Jiang W, Gao YH, Tian F, Zhao L, Wang S.
    Ann Surg Oncol; 2010 Jul 26; 17(7):1937-44. PubMed ID: 20162464
    [Abstract] [Full Text] [Related]

  • 18. Antisense RhoC gene suppresses proliferation and invasion capacity of human QBC939 cholangiocarcinoma cells.
    Shi Z, Chen ML, He QL, Zeng JH.
    Hepatobiliary Pancreat Dis Int; 2007 Oct 26; 6(5):516-20. PubMed ID: 17897917
    [Abstract] [Full Text] [Related]

  • 19. [Effect of down regulation of laminin receptor on urokinase-type plasminogen activator expression in human bile duct carcinoma cells].
    Wang SG, Chen CH, Li DJ, Li K.
    Zhonghua Yi Xue Za Zhi; 2004 Oct 02; 84(19):1642-4. PubMed ID: 15569461
    [Abstract] [Full Text] [Related]

  • 20. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
    Soler M, McHutchison JG, Kwoh TJ, Dorr FA, Pawlotsky JM.
    Antivir Ther; 2004 Dec 02; 9(6):953-68. PubMed ID: 15651754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.